Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedestimated completion
- Principal Investigator
- by Zev A. Wainberg (ucla)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UC Cancer
- Zev A. Wainberg (ucla)
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Novartis Pharmaceuticals
- ID
- NCT03798626
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Last Updated